The US FDA's reduced requirements for preclinical animal testing have sparked a surge of interest in organoids, tissue chips, and in silico testing.
The US Food and Drug Administration has reduced requirements for preclinical animal testing, leading to a surge of interest in organoids, tissue chips and in silico testing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据